← Back to Search

Yogic Breathing for Sleep Improvement

N/A
Waitlist Available
Led By Selda Yildiz, PhD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks (8-week interventions and 2 weeks pre- and post-intervention period).
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the effects of a yogic breathing practice on sleep quality, stress reduction, and overall quality of life in healthy individuals. Participants will join regular online group sessions and do home exercises. The breathing exercises are expected to help participants relax and manage stress, which may improve their sleep.

Who is the study for?
This trial is for adults aged 18-65 who can lie down comfortably, have compatible devices for tracking physiological data, and are new to breathwork practices. It's not suitable for those on brain-affecting meds, with major psychiatric conditions or substance abuse issues, respiratory or heart problems, pregnant/nursing women, or diagnosed sleep disorders.
What is being tested?
The study aims to see if 8 weeks of yogic breathing exercises can improve sleep quality and overall life satisfaction while reducing stress. Participants will be randomly assigned to one of two different breathing practice groups.
What are the potential side effects?
Since the intervention involves non-invasive breathing techniques, significant side effects are not anticipated. However, participants may experience mild discomfort like dizziness or shortness of breath during the practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks (8-week interventions and 2 weeks pre- and post-intervention period).
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks (8-week interventions and 2 weeks pre- and post-intervention period). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sleep efficiency (SE)
Wake after sleep onset (WASO)
Secondary study objectives
36-Item Short Form Survey Instrument (SF-36)
Perceived Stress Scale (PSS)
Pittsburgh Sleep Quality Index (PSQI)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Breathing Group 1Experimental Treatment1 Intervention
Arm 1 will receive an 8-week remotely delivered intervention that consists of a set of breathing practices through 60-minute weekly virtual group sessions (1day/week) with a 20-minute daily home sessions (in between weekly sessions; 6 days/week).
Group II: Breathing Group 2Active Control1 Intervention
Arm 2 will receive an 8-week remotely delivered intervention that consists of slow breathing practices through 60-minute weekly virtual group sessions (1day/week) with a 20-minute daily home sessions (in between weekly sessions; 6 days/week).

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for sleep, such as yogic breathing practices, work by regulating the autonomic nervous system and reducing stress. These practices involve controlled breathing, mindfulness, and relaxation techniques that decrease sympathetic nervous system activity (responsible for the 'fight or flight' response) and enhance parasympathetic activity (promoting 'rest and digest' functions). This shift helps lower heart rate and blood pressure, reduce anxiety, and promote a state of calm conducive to sleep. For sleep patients, these mechanisms are crucial as they directly address stress and autonomic imbalances, which are often at the root of sleep disturbances.
Non-pharmacological interventions for sleep promotion in hospitalized children.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,159,537 Total Patients Enrolled
6 Trials studying Sleep
1,494 Patients Enrolled for Sleep
National Center for Complementary and Integrative Health (NCCIH)NIH
853 Previous Clinical Trials
671,645 Total Patients Enrolled
6 Trials studying Sleep
873 Patients Enrolled for Sleep
Oregon Health and Science UniversityLead Sponsor
1,002 Previous Clinical Trials
7,412,235 Total Patients Enrolled
7 Trials studying Sleep
1,545 Patients Enrolled for Sleep

Media Library

Breathing Group 1 Clinical Trial Eligibility Overview. Trial Name: NCT05756686 — N/A
Sleep Research Study Groups: Breathing Group 1, Breathing Group 2
Sleep Clinical Trial 2023: Breathing Group 1 Highlights & Side Effects. Trial Name: NCT05756686 — N/A
Breathing Group 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT05756686 — N/A
~46 spots leftby Nov 2025